Evidence map›Paper›PMID 38577609›Full record

ArticleJournal of Cancer2024

circular RNA circ-231 promotes protein biogenesis of TPI1 and PRDX6 through mediating the interaction of eIF4A3 with STAU1 to facilitate unwinding of secondary structure in 5' UTR, enhancing progression of human esophageal squamous cell carcinoma (ESCC).

Guo-Wei Huang, Ti-Qun Yang, Qian-Qian Chen, Xing-Mu Liu, Ling-Hui Xie, Wei Huang, Xue-Ling Chen, Yi-Qun Geng, Jiang Gu

Abstract read
In one paragraph

Article in Journal of Cancer, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Review
  2. Review
  3. Circular RNAs and Cancers.Advances in experimental medicine and biology · 2025
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Guo-Wei HuangDepartment of Pathology, Shantou University Medical College, Shantou, 515041, Guangdong, P.R. China.
Ti-Qun YangDepartment of Pathology, Shantou University Medical College, Shantou, 515041, Guangdong, P.R. China.
Qian-Qian ChenDepartment of Pathology, Shantou University Medical College, Shantou, 515041, Guangdong, P.R. China.
Xing-Mu LiuDepartment of Surgery, Second Affiliated Hospital, Shantou University Medical College, Shantou, 515041, Guangdong, P.R. China.
Ling-Hui XieDepartment of Pathology, Shantou University Medical College, Shantou, 515041, Guangdong, P.R. China.
Wei HuangDepartment of Pathology, Shantou University Medical College, Shantou, 515041, Guangdong, P.R. China.
Xue-Ling ChenDepartment of Pathology, Shantou University Medical College, Shantou, 515041, Guangdong, P.R. China.
Yi-Qun GengDepartment of Pathology, Shantou University Medical College, Shantou, 515041, Guangdong, P.R. China.
Jiang GuDepartment of Pathology, Shantou University Medical College, Shantou, 515041, Guangdong, P.R. China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

circ-231eIF4A3InteractionRNA binding proteinSTAU1

Identifiers

PMID38577609
PMCPMC10988296

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.